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In Pursuit of Science-based Regulation: FDA, FTC, and the Regulation of 
Pseudoscience 
What does “natural” mean?  
The Food and Drug Administration (“FDA”) has posed this seemingly innocuous question to 
the public in a recent request for information.1 Aside from it being a truly interesting, if overly 
philosophical question to ask the public, the move is emblematic of a recent trend, both from the 
(“FDA”) and the Federal Trade Commission (“FTC”), to regulate based on some articulable 
scientific premise, rather than allowing various actors to make wide-ranging claims about their 
products without repercussion. 2  In particular, the agencies have begun targeting dietary 
supplement manufacturers, homeopathic remedies, and most recently, Lumosity.  
Lumosity and the FTC 
Lumosity advertises copiously on networks and websites that include “CNN, Fox News, the 
History Channel, National Public Radio, Pandora, Sirius XM, and Spotify.” 3 Created by “Lumos 
Labs,” Lumosity is a web-based product consisting of 40 games, which Lumosity claimed that, 
when played “10 to 15 minutes three or four times a week could help users achieve their ‘full 
potential in every aspect of life.’”4  
The FTC got involved because Lumos Labs claimed playing Lumosity’s games would 
1) improve performance on everyday tasks, in school, at work, and in athletics; 2) delay age-
related cognitive decline and protect against mild cognitive impairment, dementia, and 
Alzheimer’s disease; and 3) reduce cognitive impairment associated with health conditions, 
including stroke, traumatic brain injury, PTSD, ADHD, the side effects of chemotherapy, and 
Turner syndrome, and that scientific studies proved these benefits. 
 
Neuroscientists have challenged such statements, noting that there is “little evidence that playing 
brain games improves underlying broad cognitive abilities, or that it enables one to better 
navigate a complex realm of everyday life.”5 In fact, at least one study seems to show that the 
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Xbox and PlayStation games actually offer some measurable benefits, while the Lumosity-type 
“brain training” games offer none.6 When commercial actors make claims that are deceptive, 
misleading, or outright false, the FTC can and should step in.7 
The FTC’s mission is to “prevent business practices that are anticompetitive or deceptive or 
unfair to consumers; to enhance informed consumer choice and public understanding of the 
competitive process.”8 In 2014, the FTC brought an action for injunctive and equitable relief 
against Lumosity.9 The FTC brought the action pursuant to its powers under the FTC Act (15 
U.S.C. §§ 41-58, as amended); in particular, those provisions involving labeling and false or 
misleading advertising.10  
Lumosity’s settlement with the FTC includes two million dollars in redress, notification to 
customers regarding the action, and an easy method of canceling auto-renewed subscriptions, as 
well as a suspended $50 million judgment against Lumos Labs.11 As Forbes listed Lumosity’s 
revenue at $23.6 million in 2013, this may prove to be a serious financial blow to the company 
and may also be indicative of the future trends in FTC enforcement actions.12  
Critics of the settlement could say that no one is harmed by false claims, such as those 
Lumos Labs and Lumosity made about its product, but the prices Lumosity charged for its 
games—with options ranging from monthly ($14.95) to lifetime ($299.95) memberships—are 
ostensibly supposed to reflect the benefits consumers expect to achieve from the products.13 If 
consumers could receive the same (or greater) benefits from, for example, free games on 
Kongregate or Addicting Games, or from console games, then Lumosity is doing nothing more 
than selling digital snake oil. The free market demands that consumers know there is no 
meaningful difference between the two, and that one may not benefit—to the detriment of the 
other—based upon misleading or untrue statements.  
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Lumosity’s claims, while misleading and injurious to the market, are surely worth the 
regulatory scrutiny applied by the FTC. Another pseudoscientific menace—dietary 
supplements—deserve at least equal regulatory scrutiny; however, the regulatory scheme for 
them has fallen woefully short of being in the best interest of public health.  
The FDA and Supplements 
The FDA is charged with the regulation of food and drugs under the Food, Drug, and 
Cosmetics Act.14 It seems like supplements would fall into one of those categories and until the 
mid-nineties, the FDA had done a good job of regulating them. Then do-it-yourself healthcare 
and “alternative medicine” became trendy, and the public (aided greatly by the moneyed-
interests in the supplements industry) decided it wanted supplements to exist in their own realm 
of little-to-no regulation, resulting in the current regulatory scheme, which leaves them largely 
unregulated and thus, in a position to do the public great harm.15 
The first example of the fallout from deregulation has to do with what is actually in the 
supplements themselves; to wit… no one can really know, unless they actually test the 
supplements (which are already for sale on the market, over the counter) to see if they contain 
the advertised product. The pertinent question, when performing such tests, isn’t always “how 
much of the product does it contain?” That remains an important question, especially since 
toxicity is a possibility, and the quantity of product actually contained in the pill may have no 
relation whatsoever to any claims on the bottle. The pertinent questions are often “does this 
actually contain the product advertised?” and “what other products does it contain?” The answers 
are often, respectively: “no” and “several, which are not on the label.” 
When New York tested supplements from GNC, Target, Walgreens, and Wal-Mart, it found 
that four out of five of the products tested contained none of the actual herb on the label.16 
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Moreover, those products often contained nothing more than houseplants, asparagus, or rice.17 A 
Canadian study of herbal products found similar results, and added that some of the substances 
found posed “serious health risks.”18 Some of these risks include chronic diarrhea and liver 
damage.19  
Even when the product actually reflects the labeling, other risks abound, particularly the risk 
of overdose and dangerous drug interactions. The “appeal to nature” fallacy—in which one poses 
that a product is “good” or “healthy” because it is “natural”—entirely dominates the world of 
alternative medicine, yet remains without scientific support.20 That is, it is not logical to assume 
that “natural” nightshade mushrooms are healthier than a Twinkie. And again, what “natural” 
means is a live debate. But this fallacious thinking can lead to dangerous overconsumption of 
supplements.21 For example, herbs like comfrey and aristolochia can cause liver and kidney 
failure.22 St. John’s Wort—commonly used as an over-the-counter antidepressant—can interact 
dangerously with other antidepressants, and other drugs.23 And since most patients don’t tell 
their physicians about their supplement use, dangerous interactions and effects can go 
undiagnosed, and untreated.24 While it may be incumbent upon physicians to ask their patients 
what supplements they are using, full disclosure by the patients does not guarantee an accurate 
appraisal. 
Supplement doses can also vary wildly from their labels, and with dangerous results. For 
example, an outbreak of selenium poisoning in 2010 was traced to a supplement containing more 
than 200 times the amount of selenium labeled, and led to acute hair and fingernail loss before 
being pulled from the market.25 And a study reported by the Journal of the American Medical 
Association found that, among 12 brands of vitamin D, pills tested could contain anywhere from 
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52 to 135 percent of the dosage found on the label, and dosage could vary not only bottle-to-
bottle, but pill-to-pill.26  
Finally, even the effectiveness of supplements is in doubt. As one medical professor has said, 
“It seems reasonable that if a little bit of something is good for you, then more should be better 
for you. It's not true. Supplementation with extra vitamins or micronutrients doesn't really benefit 
you if you don't have a deficiency.”27 A science-based approach to medicine has consistently 
shown that any benefits from “complementary and alternative medicine” (“CAM”) either 
disappear as placebo effects or anecdotal anomaly. 28  Some have gone as far as to say that 
“alternative medicine” is illusory. Dr. Paul Offit, a leading pediatrician, has observed “there’s no 
such thing as alternative medicine. If clinical trials show that a therapy works, it’s good 
medicine. And if a therapy doesn’t work, then it’s not an alternative.”29 Those who believe that 
“alternatives” to conventional health care are easy victims for modern day snake oil salesmen 
who, not coincidentally, benefit from the lack of regulation.30 Thus, Congress’ leashing of the 
FDA makes no sense, when regulating supplements could easily remedy these problems. 
Sometimes, though, acutely dangerous instances arise in supplements, and the government 
can actually take direct action. For example, in November 2015, the FDA announced results of a 
yearlong sweep of the supplements industry that resulted in civil injunctions and criminal actions 
(in partnership with the Department of Justice) against 117 supplements manufacturers. 31 
Included among those manufacturers was USPlabs, a popular fitness supplements producer.32 
Their product, OxyElitePro, was linked to many cases of hepatitis, including some so severe that 
they resulted in liver transplants and at least one death.33 Because supplement manufacturers 
need not prove the safety of their products before bringing them to market, USPlabs’ indictment 
was not for the introduction of a dangerous product to customers. Instead, when the FDA 
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brought the danger to USPlabs attention, its principals said they would take the supplement off 
the market, but instead “engaged in a surreptitious, all-hands-on-deck effort to sell as much 
OxyElite Pro as it could as quickly as possible.”34 It was their knowing introduction of the 
supplement to the market that brought the indictment. Thus, if an industry actor does not 
knowingly introduce a harmful supplement into the marketplace, it is not criminally liable. In 
other words, the less a manufacturer knows about adverse health effects of supplements, the less 
susceptible it is to prosecution. The supplements industry, then, has an interest in not knowing 
whether one if its products harms the public. This perversion of the regulatory scheme can only 
be fixed through an act of Congress. And while Congress is at it, perhaps it will finally take a 
closer look at another pseudoscientific scheme that has escaped regulatory notice for too long: 
homeopathy. 
FDA, FTC, and homeopathy 
Homeopathy is a theory of “medicine” developed in Germany in the late 1700s:  
Supporters of homeopathy point to two unconventional theories: “like cures like”—the notion that 
a disease can be cured by a substance that produces similar symptoms in healthy people; and “law 
of minimum dose”—the notion that the lower the dose of the medication, the greater its 
effectiveness.35 
 
To give you a better grasp of what this means practically, imagine that you have an allergy to 
cats, which causes a runny nose and itchy eyes. A homeopathic remedy for that allergy may 
contain red onion (“Allium Cepa”), because red onion also causes runny nose and itchy eyes.36 
The red onion will then often be diluted to “30C,” which means it is diluted, with water to 1060-
fold dilution.37  Effectively, this means it is doubtful that even one molecule of the active 
ingredient can still be found in the product.38  
Homeopathy is exactly as implausible and ineffective as it sounds.39 Despite any scientific 
evidence for its effectiveness, homeopathy has gained a sizeable following in the U.S., such that 
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in 2012, an estimated 5 million adults and 1 million children used homeopathic “remedies,” and 
it is a billion-dollar industry.40  
The FDA’s current regulatory scheme for homeopathic “drugs” is light, to say the least. In 
order to sell a homeopathic “drug,” a manufacturer must only show that its “drug” is found in the 
Homeopathic Pharmacopeia of the United States (“HPUS”) and its supplements, and conform to 
all other labeling provisions for over the counter (“OTC”) drugs.41 If found in the HPUS, it is 
presumed to be generally recognized as safe and effective (“GRASE”), despite the fact that no 
one has ever (nor could they plausibly) proven the effectiveness of homeopathy.  
Recently, the FDA opened the subject to public comment and, interestingly, the FTC was one 
of the commenters.42 The FTC is interested in homeopathy specifically because “[f]or health, 
safety, or efficacy claims, the FTC has generally required that advertisers possess ‘competent 
and reliable scientific evidence.’”43 As noted above, homeopathic “drug” manufacturers cannot 
point to any such evidence for any claims. They are thus technically in conflict with the FTCA; 
but the FTC had deferred to FDA, because the Agency regulates homeopathy. 
While consumers may wonder what harm exists in allowing the uninformed to buy 
potentially ineffective remedies, in the area of health care, the remedies that patients choose to 
pursue may exclude other remedies. For example, someone who prefers homeopathy to real 
medicine may choose to forgo a flu vaccine in favor of the homeopathic alternative.44 Influenza 
and pneumonia are one of the leading causes of death in the U.S. and worldwide, leading to 
almost 58,000 deaths in the U.S. in 2013, and between 250,000 and 500,000 deaths worldwide, 
annually.45 If even one of those deaths could be prevented by a person choosing a real flu 
vaccine over its homeopathic “alternative,” it is more than worth regulating homeopathy.  
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Consumers are better served by having a health care system, and a regulatory structure in 
general, that is science-based. Homeopathy is a belief in magic, not science. It is fundamentally 
no different than faith healing, or leeching out bad humours. It is anachronistic and 
fundamentally flawed. Giving it the legitimacy of a free pass from our regulatory agencies stains 
the esteem of the United States’ medical prowess and our stance among the finest medical elites 
in the world. We as a nation have made great strides toward medicine based upon science; we 
should have a regulatory structure, and a legal system, similarly subject to scientific rigor. 
Conclusion 
Who knows what “natural” means? In the end, does it really matter? One can hope that the 
FDA’s question actually leads to a better understanding of science, and the arbitrariness of some 
of the words we use. But more importantly, the FDA and FTC must continue what looks like a 
trend of protecting the public from pseudoscience and the horrors of the anti-science community. 
Let’s have science-based law, to go along with our health policy.  
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